|
BPTF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65167879373485E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.80460149232931E-11 |
| Normal-vs-Stage2 |
4.96439999997378E-07 |
| Normal-vs-Stage3 |
2.18713935851156E-14 |
| Normal-vs-Stage4 |
2.69717581602436E-12 |
| Stage1-vs-Stage2 |
9.722600E-01 |
| Stage1-vs-Stage3 |
2.774200E-02 |
| Stage1-vs-Stage4 |
1.570410E-02 |
| Stage2-vs-Stage3 |
1.298580E-01 |
| Stage2-vs-Stage4 |
1.087360E-01 |
| Stage3-vs-Stage4 |
7.618600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14908083048704E-13 |
| Normal-vs-AfricanAmerican |
3.183100E-04 |
| Normal-vs-Asian |
4.25459999453537E-08 |
| Caucasian-vs-AfricanAmerican |
2.236400E-01 |
| Caucasian-vs-Asian |
7.072200E-01 |
| AfricanAmerican-vs-Asian |
3.846000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47659662275146E-14 |
| Normal-vs-Female |
4.38449276884967E-12 |
| Male-vs-Female |
2.343200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.90769963662285E-10 |
| Normal-vs-Age(41-60Yrs) |
3.27570193192628E-11 |
| Normal-vs-Age(61-80Yrs) |
1.85806925401266E-12 |
| Normal-vs-Age(81-100Yrs) |
4.46499999999794E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.849800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.178000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.498000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.664200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.768000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.785800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.590200E-04 |
| Classical-VS-Follicular |
4.083500E-02 |
| Classical-VS-Other |
3.612000E-01 |
| Classical-VS-Normal |
2.0840995595961E-11 |
| Tall-VS-Follicular |
2.553800E-01 |
| Tall-VS-Other |
5.931800E-01 |
| Tall-VS-Normal |
5.58375568004976E-12 |
| Follicular-VS-Other |
9.338600E-01 |
| Follicular-VS-Normal |
6.08689987302569E-10 |
| Other-VS-Normal |
1.357750E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05569997188582E-11 |
| Normal-vs-N1 |
7.63822338711861E-12 |
| N0-vs-N1 |
1.850820E-01 |
|
|
